CCL International Limited (BOM:531900)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 25, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	529	509	426	273	325	329
Market Cap Growth	19.42%	19.42%	56.16%	-16.16%	-1.17%	602.87%
Enterprise Value	698	639	532	285	402	440
Last Close Price	27.55	26.50	22.19	14.21	16.95	17.15
PE Ratio	74.46	71.04	29.04	-	57.16	68.95
PS Ratio	1.15	1.11	1.19	1.66	1.21	1.09
PB Ratio	1.12	1.08	0.92	0.61	0.70	0.72
P/TBV Ratio	1.12	1.08	0.92	0.61	0.70	0.72
P/FCF Ratio	118.25	113.74	-	13.26	-	3.67
P/OCF Ratio	32.43	31.19	-	8.58	-	3.40
EV/Sales Ratio	1.52	1.40	1.49	1.73	1.50	1.46
EV/EBITDA Ratio	15.46	14.16	11.29	66.10	11.73	10.85
EV/EBIT Ratio	38.02	34.83	28.54	-	46.09	30.58
EV/FCF Ratio	156.02	142.91	-	13.84	-	4.91
Debt / Equity Ratio	0.52	0.52	0.52	0.32	0.29	0.20
Debt / EBITDA Ratio	5.39	5.39	5.17	33.67	3.94	2.24
Debt / FCF Ratio	54.46	54.46	-	7.05	-	1.01
Asset Turnover	0.61	0.61	0.52	0.26	0.42	0.46
Inventory Turnover	3.16	3.16	2.25	1.25	3.14	2.88
Quick Ratio	0.76	0.76	0.81	0.86	1.32	1.18
Current Ratio	2.09	2.09	2.17	3.05	2.53	2.98
Return on Equity (ROE)	1.53%	1.53%	3.20%	-3.03%	1.23%	1.04%
Return on Assets (ROA)	1.53%	1.53%	1.71%	-1.99%	0.85%	1.36%
Return on Capital (ROIC)	1.61%	1.61%	1.79%	-2.13%	0.95%	1.53%
Return on Capital Employed (ROCE)	3.80%	3.80%	3.80%	-	1.80%	3.00%
Earnings Yield	1.35%	1.41%	3.44%	-5.10%	1.75%	1.45%
FCF Yield	0.85%	0.88%	-13.09%	7.54%	-22.12%	27.26%
Buyback Yield / Dilution	-0.81%	-0.81%	-	-0.00%	-	-
Total Shareholder Return	-	-0.81%	-	-0.00%	-	-

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.